BYD misses quarterly earnings forecasts due to supplier payments crackdown - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
比亚迪

BYD misses quarterly earnings forecasts due to supplier payments crackdown

Chinese carmaker’s revenues also affected by Beijing’s campaign against discounting which has cooled EV price war
00:00

{"text":[[{"start":11.18,"text":"China’s electric vehicle champion BYD reported lower than expected earnings for the second quarter, hit by Beijing’s crackdown on aggressive discounting and long-term supplier payment practices. "}],[{"start":25.36,"text":"The group’s first decline in quarterly profits for the first time in more than three years comes as growth in the Chinese EV market loses steam. The Shenzhen-based carmaker, which is vying for the world’s top EV maker position with Tesla, is eyeing further expansion overseas."}],[{"start":46.21,"text":"BYD’s net income dropped almost 30 per cent to Rmb6.4bn ($897mn), missing analysts’ expectations of Rmb10.7bn. The carmaker recorded a 14 per cent year-on-year rise in revenue to Rmb201bn in the three-month period, falling short of consensus forecasts of Rmb220bn. "}],[{"start":76.69,"text":"Second-quarter gross margin dropped to 16.3 per cent from 18.7 per cent a year earlier, as the company was forced to amend its supplier payment practices."}],[{"start":92.08,"text":"BYD promised in June to more than halve payment times to suppliers to 60 days, after Chinese regulators warned a dozen domestic car manufacturers against aggressive price cuts and mounting unpaid bills. BYD has long been criticised by suppliers for its long payment terms and issuance of promissory notes as an alternative to cash."}],[{"start":118.57,"text":"Exchanging faster payments for lower component pricing has been another common tactic used by BYD and its local peers."}],[{"start":128.91,"text":"The price war in China’s EV market has also cooled off, as the country’s top officials recently launched a counteroffensive against aggressive discounting on the back of surging production, known as neijuan. The average discount offered by 11 major carmakers in China, including BYD and Tesla, narrowed to 6.7 per cent in early August from a peak of 8 per cent in the second half of June, according to Citi analysts."}],[{"start":161.95,"text":"The auto sector has been among the key targets in Beijing’s campaign against neijuan. The price cuts have been adding to China’s stubborn deflationary pressures, one of China’s key economic problems, and fuelling tensions with the country’s biggest trading partners as companies turn to exports. "}],[{"start":182.79999999999998,"text":"The results announcement came after the market close on Friday, but ahead of the report, BYD’s shares had fallen 25 per cent from a record high in May, when the group’s “God’s Eye” advanced driver-assistance system and the release of its five-minute battery charging technology buoyed investor optimism. "}],[{"start":204.08999999999997,"text":"Outside the competitive home market, BYD is enjoying greater momentum abroad. The group’s overseas sales of battery-powered vehicles and plug-in hybrids more than doubled to 550,000 units in the first seven months of the year. "}],[{"start":221.22999999999996,"text":"BYD is benefiting from Tesla’s recent retreat in Europe, where the Chinese automaker sold more EVs than the Elon Musk-led group for the first time in May. With its inroads into the continent coinciding with a consumer backlash against Musk’s political activism, BYD’s plan to start production at its new Hungary and Turkey factories as soon as this year is expected to expand its global footprint and cushion tariff risks. "}],[{"start":252.70999999999995,"text":"The Warren Buffett-backed company has built a fleet of six car-carrying “roll-on, roll-off” ships for exports, the management said in a filing on Friday, while hinting at adding more overseas production capacity to “fully prepare for a surge in international demand”."}],[{"start":281.23999999999995,"text":""}]],"url":"https://audio.ftmailbox.cn/album/a_1756683966_5904.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

武田制药与信达生物达成重磅双特异性抗体、ADC合作,预付款12亿美元

正在进行大规模管线转型的武田制药达成了今年规模最大的研发预付款合作之一。而且,与今年三分之一以上的生物医药许可交易类似,这笔交易也涉及一家中国药物开发公司。
4小时前

稀土矿商的价值能永远上涨吗?

更高的价格将使生产商能在中国以外扩大产能,但市场上确实弥漫着明显的亢奋情绪。

欧洲很难在囤积关键矿产的竞赛中迎头赶上

布鲁塞尔将在年底前启动磋商,讨论储备对国防和绿色技术至关重要的矿产。

美中在至关重要的特习峰会前启动贸易谈判

华盛顿称斯科特•贝森特与何立峰首日谈判“非常有建设性”。

“ADC十年”仍在继续,阿斯利康、科伦药业和默克将在#ESMO25上公布数据

两年前,在欧洲医学肿瘤学会的年度会议上,一位知名肿瘤科医生预言,2020年代将是“ADCs的十年”。

特朗普正在成为“最高领袖”吗?

对手四分五裂、盟友步调一致、追随者如痴如醉——美国总统已在迈向构建新世界秩序的道路上。
设置字号×
最小
较小
默认
较大
最大
分享×